Skip to content
Search

Latest Stories

Gambia hires US law firm to consider action on toxic Indian cough syrup, minister says

At least 70 children died from acute kidney injury in the African country between June and October

Gambia hires US law firm to consider action on toxic Indian cough syrup, minister says

Gambia has hired a US law firm to explore legal action after a government-backed investigation found that contaminated medicines from India were "very likely" to have caused the deaths of children last year, the justice minister said.

At least 70 children in Gambia, most under fiver years old, died from acute kidney injury between June and October.

Local doctors suspected cough syrups imported from India were the likely culprit, Reuters reported earlier this year, and tests by the World Health Organization (WHO) confirmed the presence of lethal toxins, sparking a global hunt for contaminated medicines.

Gambian justice minister Dawda Jallow said legal action was one option under consideration by the government, the first sign of potential international litigation over the deaths. Jallow did not say who would be the target of potential legal proceedings or name the law firm hired to help.

The medicines linked to the children's deaths were made by Indian drug maker Maiden Pharmaceuticals, which denied wrongdoing.

Tests by the WHO found that the Maiden cough syrups contained the lethal toxins diethylene glycol (DEG) and ethylene glycol (EG), used in car brake fluid. India's government has said its own tests on the drugs found no toxins.

India's health ministry and Maiden did not respond to requests for comment on Gambia's possible legal action. The WHO declined to comment.

Indian officials have said the WHO failed to prove a causal link to the Gambia deaths, accusing the agency of denigrating its $41 billion pharmaceutical industry. However, cough syrups made by a second Indian drugmaker have been linked to the deaths of 19 children in Uzbekistan. India has since made drug testing mandatory for cough syrups before export.

Gambia's justice ministry is considering its options after completion of a new government-commissioned causality assessment by a panel of international experts, Jallow said.

Reuters has seen a copy of the report, which was presented to President Adama Barrow in April but has not been made public.

In it, experts said they analysed 56 of the cases of acute kidney injury. Of those, they found 22 were "very likely" to have died from DEG or EG poisoning after taking Maiden products.

The panel could not confirm the cause of death in another 30 cases but said it was "highly suggestive" they were killed by DEG and EG. It said there was not enough evidence in four other cases.

Doctors were able to carry out autopsies on just two of the patients. The pathology from both was consistent with DEG and EG poisoning, the report said. Of all the medicines tested after the deaths, only Maiden's were shown to be toxic, it said.

DEG and EG can be used by unscrupulous actors as a cheap substitute for propylene glycol, a key ingredient in syrupy medicines, according to several pharmaceutical manufacturing experts.

Reuters could not determine if Indian authorities had seen the causality report.

It is the latest piece of a months-long investigation into the deaths, which raised concerns among global health officials about lax regulation in India's drug sector and oversight of pharmaceutical raw materials worldwide. Many of the countries India supplies, including Gambia, have no means of testing imported drugs.

The WHO has said it is continuing to investigate the source of contaminated cough syrups in Gambia, Uzbekistan and several other countries, but has been frustrated by a lack of information regarding Maiden's drugs. A key middleman in the supply chain of those medicines is still unknown.

Gambia's minister Dawda said the causality assessment and the justice ministry's recommendations would be made public within six months.

Gambia is planning to build a testing facility for imported drugs with support from the World Bank, the bank said.

(Reuters)

More For You

Trump says 'won’t get Nobel' as Pakistan backs 2026 nomination

Donald Trump walks out of the Oval Office before boarding Marine One on the South Lawn of the White House on June 20, 2025 in Washington, DC. (Photo by Kayla Bartkowski/Getty Images)

Trump says 'won’t get Nobel' as Pakistan backs 2026 nomination

PAKISTAN government has announced that it will formally nominate US president Donald Trump for the 2026 Nobel Peace Prize, citing his “decisive diplomatic intervention” during the recent military tensions between India and Pakistan.

The announcement was made on Saturday (21) on X, just days after president Trump hosted Pakistan Army Chief general Asim Munir at the White House.

Keep ReadingShow less
King Charles praises yoga as thousands join global celebrations

Yoga Day celebrations in the UK (Photo: X/@HCI_London)

King Charles praises yoga as thousands join global celebrations

HUNDREDS of people gathered in central London on Friday (20) evening to mark the 10th International Day of Yoga, with King Charles III sending a special message of support for the ancient practice that continues to grow in popularity across Britain.

The celebration took place at an iconic square on the Strand, organised by the Indian High Commission in partnership with King's College London. High commissioner Vikram Doraiswami opened the proceedings by reading out the King's personal message from Buckingham Palace.

Keep ReadingShow less
Parliament backs assisted dying in historic law shift

Supporters of the assisted dying law for terminally ill people hold a banner, on the day British lawmakers are preparing to vote on the bill, in London, Britain, June 20, 2025. REUTERS/Isabel Infantes

Parliament backs assisted dying in historic law shift

PARLIAMENT voted on Friday (20) in favour of a bill to legalise assisted dying, paving the way for the country's biggest social change in a generation.

314 lawmakers voted in favour with 291 against the bill, clearing its biggest parliamentary hurdle.

Keep ReadingShow less
Air India

An Air India Airbus A320-200 aircraft takes off from the Sardar Vallabhbhai Patel International Airport in Ahmedabad, India, July 7, 2017. Picture taken July 7, 2017.

Regulator warns Air India over delayed emergency equipment checks: Report

INDIA’s aviation regulator has warned Air India for violating safety rules after three of its Airbus aircraft operated flights without undergoing mandatory checks on emergency escape slides, according to official documents reviewed by Reuters.

The Directorate General of Civil Aviation (DGCA) issued warning notices and a detailed investigation report highlighting the breach. These documents were sent days before the recent crash of an Air India Boeing 787-8, in which all but one of the 242 people onboard were killed. The Airbus incidents are unrelated to that crash.

Keep ReadingShow less
assisted dying bill

Pro and anti-assisted dying campaigners protest ahead of a parliamentary decision later today, on June 20, 2025 in London.

Getty Images

MPs to vote on assisted dying bill amid divided views

UK MPs are set to hold a key vote on assisted dying on Friday, which could either advance or halt a proposed law that would allow terminally ill adults to end their lives under strict conditions.

The vote follows several hours of debate in the House of Commons and will decide whether the Terminally Ill Adults (End of Life) Bill moves to the House of Lords for further scrutiny or is dropped altogether.

Keep ReadingShow less